Improved prediction of long-term, other cause mortality in men with prostate cancer.
暂无分享,去创建一个
Sheldon Greenfield | Mark S Litwin | Karim Chamie | Jessica Labo | S. Greenfield | T. Daskivich | M. Litwin | K. Chamie | A. Dash | L. Kwan | Timothy J Daskivich | Lorna Kwan | Atreya Dash | Jessica Labo
[1] M. Cowen,et al. Predicting life expectancy in men with clinically localized prostate cancer. , 2006, The Journal of urology.
[2] Hans Garmo,et al. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer , 2011 .
[3] J. Fowler,et al. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. , 1996, The Journal of urology.
[4] M. Menon,et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. , 2004, The Journal of urology.
[5] Anthony D'Amico,et al. Prostate cancer. Clinical practice guidelines in oncology. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.
[6] S. Boorjian,et al. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. , 2008, The Journal of urology.
[7] L. Bouter,et al. How to measure comorbidity. a critical review of available methods. , 2003, Journal of clinical epidemiology.
[8] F. Saad,et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] F. Saad,et al. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy , 2008, BJU international.
[10] J L Warren,et al. Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.
[11] A. D'Amico,et al. Guideline for the management of clinically localized prostate cancer: 2007 update. , 2007, The Journal of urology.
[12] J. Hanley,et al. Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer , 1998 .
[13] A. Renshaw,et al. Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .
[14] D. Fryback,et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. , 1996, The Journal of urology.
[15] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.